Re: Diagnosing myasthenia gravis in older patients: Comments and observations
暂无分享,去创建一个
J. Schold | N. Silvestri | Yuebing Li | Ikjae Lee | M. Hehir | B. Claytor
[1] J. Schold,et al. Validation of myasthenia gravis diagnosis in the older Medicare population , 2022, Muscle & nerve.
[2] R. Iorio,et al. Controversies in Ocular Myasthenia Gravis , 2020, Frontiers in Neurology.
[3] A. Vincent,et al. False-positive acetylcholine receptor antibody results in patients without myasthenia gravis , 2019, Journal of Neuroimmunology.
[4] P. Nichelli,et al. Factors affecting outcome in ocular myasthenia gravis , 2018, The International journal of neuroscience.
[5] K. Kondo,et al. Late-onset myasthenia gravis is predisposed to become generalized in the elderly , 2016, eNeurologicalSci.
[6] J. Lemos,et al. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis. , 2015, JAMA neurology.
[7] J. Lemos,et al. Prognosis of Ocular Myasthenia Gravis: Retrospective Multicenter Analysis. , 2015, Ophthalmology.
[8] D. Lacomis,et al. Characteristics of late-onset myasthenia gravis , 2012, Journal of Neurology.
[9] J. Kira,et al. Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey , 2011, Journal of the Neurological Sciences.
[10] K. Kondo,et al. Increasing incidence of elderly onset patients with myasthenia gravis in a local area of Japan , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[11] G. Plant,et al. Ocular Myasthenia Gravis: Controversies and Updates , 2013, Current Neurology and Neuroscience Reports.